| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 02/01/2006 | CN1729171A Modulation of anxiety through blockade of anandamide hydrolysis |
| 02/01/2006 | CN1727331A Equipment of preparing birueal by using carbamide as raw material |
| 01/31/2006 | US6991746 Polymeric allophanates of diphenylmethane diisocyanate, perpolymers of these polymeric allophanates, and processes for the preparation of the polymeric allophanates and the prepolymers thereof |
| 01/31/2006 | CA2148783C Process for the production of light-stable polyisocyanates containing allophanate groups |
| 01/26/2006 | US20060019900 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 01/25/2006 | EP1619189A1 N-(3-acyl-2-hydroxyalkyl) cycloalkyl amide derivatives |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP1617803A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 01/25/2006 | CN1726187A Substituted tetralins and indanes and their use |
| 01/24/2006 | US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/24/2006 | CA2350881C Wet adhesion monomer and derived copolymers for latex paints |
| 01/19/2006 | WO2006006725A1 Phenol compound, reversible thermosensitive recording medium, reversible thermosensitive recording label, reversible thermosensitive recording member, image-processing apparatus and image-processing method |
| 01/18/2006 | EP1616867A1 Hydroxycarboxylic acid derivatives |
| 01/18/2006 | EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 01/18/2006 | EP1616859A1 Substituted cyclohexyl carboxylic acid compounds |
| 01/18/2006 | EP1615878A2 Compounds, compositions and methods |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1723192A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 01/18/2006 | CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 01/12/2006 | WO2006003923A1 Substituted benzene compound |
| 01/12/2006 | US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/12/2006 | CA2570213A1 Alpha-helical mimetics |
| 01/12/2006 | CA2566648A1 Guanylhydrazone salts, compositions, processes of making and methods of using |
| 01/11/2006 | CN1236000C Electronic donor compound capable of solidifying |
| 01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
| 01/10/2006 | US6984661 for preventing, Syndrome X, diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis, and other disorders related to Syndrome X and cardiovascular diseases; peroxisome proliferator activated receptor (PPAR) |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | CN1234686C Synthesis process of benzoyl substituted carbamide compound |
| 01/03/2006 | US6982348 for example, N[(1RS2SR)-2-(4-fluorophenyl)-2-hydroxy-1-[4-fluoromethyl)benzyl]ethyl]-6,7-dihydro-5H-benzo[a]cycloheptene-1-carboxamide; cholesteryl ester transfer protein inhibitory action; lipid-lowering agents |
| 12/29/2005 | WO2005123666A1 Vanilloid trpv1 receptor antagonists |
| 12/29/2005 | US20050288369 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | CA2570248A1 Polycationic compounds and uses thereof |
| 12/28/2005 | EP1608645A1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 12/28/2005 | EP1608616A1 Biphenyl carboxylic amide p38 kinase inhibitors |
| 12/28/2005 | EP1608319A2 Improved inhibitors for the soluble epoxide hydrolase |
| 12/28/2005 | EP1299352B1 Compounds to treat alzheimer's disease |
| 12/28/2005 | CN1714076A Novel aryl ureido benzoic acid derivatives and their use |
| 12/22/2005 | WO2005122379A2 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 12/22/2005 | WO2005061443A3 Benzoyl-substituted phenylalanine amides |
| 12/22/2005 | WO2004098512A3 Malonamides and malonamide derivatives as modulators of chemokine receptor activity |
| 12/22/2005 | US20050282882 Diamines as modulators of chemokine receptor activity |
| 12/22/2005 | US20050282876 Inhibitors of IMPDH enzyme |
| 12/22/2005 | CA2727841A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido [2, 3-d] pyrimidine derivatives and related compounds |
| 12/21/2005 | CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 12/14/2005 | EP1603891A1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid |
| 12/14/2005 | EP1603864A2 Diphenylethylene compounds and uses thereof |
| 12/14/2005 | EP1224165B1 Novel compounds |
| 12/14/2005 | CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 12/14/2005 | CN1231464C Novel 3-substituted urea derivatives and medicinal use thereof |
| 12/14/2005 | CN1231212C Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
| 12/13/2005 | US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors |
| 12/13/2005 | US6974836 Diamines as modulators of chemokine receptor activity |
| 12/13/2005 | US6974828 3-((2-((3-((Amino(imino)methyl)amino)benzoyl)amino)phenyl)sulf anyl)- 3-(3-pyridinyl)propanoic acid, for example; angiogenic inhibitors; antitumor, -carcinogenic, -metastatic, -diabetic, -arthritic and inflammatory agents; bone disorders |
| 12/08/2005 | US20050272638 Improved bioavailability; for oral and intracolonic administration |
| 12/07/2005 | EP1169303B1 Aryl-chloroalkyl ureas |
| 12/07/2005 | EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 12/07/2005 | EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 12/07/2005 | CN1705642A Novel N-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same |
| 12/07/2005 | CN1230457C Compound with isocyanate group, coating composite containing same, and preparation and use thereof |
| 12/06/2005 | US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 12/06/2005 | US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 12/06/2005 | CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| 12/06/2005 | CA2096528C Retroviral protease inhibitors |
| 12/01/2005 | WO2005114331A1 Resist compound and resist composition |
| 12/01/2005 | WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 12/01/2005 | WO2005082862A3 Benzimidazolyl derivatives as kinase inhibitors |
| 12/01/2005 | US20050267215 Abca-1 elevating compounds |
| 12/01/2005 | US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma |
| 12/01/2005 | US20050267119 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 11/30/2005 | EP1599443A1 Cycloalkyl-substituted alkanoic acid derivatives, methods for the production thereof, and use thereof as a medicament |
| 11/24/2005 | US20050261524 reacting at least one corresponding amine with phosgene in the presence of an aqueous inorganic base at a temperature in the range from 0 to 150 degrees C; high space-time yield; continuous reaction |
| 11/24/2005 | US20050261503 Heteroaromatic glucokinase activators |
| 11/24/2005 | US20050261446 Low-cure powder coatings and methods for using the same |
| 11/24/2005 | US20050261358 Cyclohexylurea compounds |
| 11/24/2005 | US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 11/23/2005 | CN1701061A New compounds for the inhibition of rotamases and use thereof |
| 11/23/2005 | CN1701059A Chemotherapeutic agents |
| 11/23/2005 | CN1699349A Method and reagents for N-alkylating ureides |
| 11/23/2005 | CN1228318C New benzoyl urea compound and its synthesis and application |
| 11/22/2005 | US6967214 Inhibitors of IMPDH enzyme |
| 11/22/2005 | CA2174016C Method and apparatus for recovering condensables in vapor from a urea vacuum evaporator |
| 11/17/2005 | WO2005108370A1 Benzene compounds |
| 11/17/2005 | WO2005108352A1 Novel biaromatic compounds which activate pparϝ-type receptors, their process of preparation and their use in cosmetic or pharmaceutical compositions |
| 11/17/2005 | WO2005107762A2 Certain chemical entities, compositions, and methods |
| 11/17/2005 | US20050256201 Phenethanolamine derivatives |
| 11/17/2005 | US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 11/17/2005 | CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 11/17/2005 | CA2563955A1 Novel biaromatic compounds which activate ppar.gamma.-type receptors, their process of preparation and their usein cosmetic or pharmaceutical compositions |
| 11/16/2005 | EP1594836A1 Hydroxy-tetrahydro-naphthalenylurea derivatives |
| 11/16/2005 | EP1252135B1 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use |
| 11/16/2005 | CN1697827A Novel o-isopropylisourea salts and process for the production thereof |
| 11/15/2005 | CA2128344C Liquid methylene diphenyl diisocyanate |
| 11/10/2005 | WO2005105737A1 Process for the preparation of substituted tetralin and substituted indane derivatives |
| 11/10/2005 | US20050250857 Gelling agents |
| 11/10/2005 | US20050250819 Inhibitors of bacterial type III protein secretion systems |
| 11/10/2005 | US20050250816 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 11/10/2005 | US20050249665 Urea-, glycerate- and, hydroxyamide-headed hydrocarbon chain lyotropic phases forming surfactants |